ADGM Adagio Medical Holdings, Inc.

Nasdaq


$ 1.38 $ -0.11 (-7.38 %)    

Wednesday, 15-Oct-2025 10:19:55 EDT
QQQ $ 606.46 $ 2.64 (0.44 %)
DIA $ 466.34 $ 1.70 (0.37 %)
SPY $ 669.73 $ 2.94 (0.44 %)
TLT $ 91.13 $ 0.17 (0.19 %)
GLD $ 387.02 $ 1.06 (0.27 %)
$ 1.71
$ 1.47
$ 1.37 x 200
$ 1.39 x 200
$ 1.34 - $ 1.48
$ 0.63 - $ 4.20
112,568
na
nm
$ -1.00
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-27-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-26-2024 06-30-2024 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Securities Purchase Agreement On October 14, 2025, Adagio Medical Holdings, Inc. (the "Company") entered into a Securit...

Core News & Articles

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or the "Company"...

Core News & Articles

97% Acute Effectiveness and Favorable Safety Results from Proprietary ULTC for Ventricular TachycardiaAdagio Medical Holdings, ...

Core News & Articles

Adagio Medical Holdings (NASDAQ:ADGM) reported quarterly losses of $(0.35) per share. This is a 95.24 percent increase over los...

Core News & Articles

Adagio Medical Holdings (NASDAQ:ADGM) reported quarterly losses of $(0.51) per share. This is a 95.04 percent increase over los...

Core News & Articles

-SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION